Efficacy of Moderately Dosed Etoposide in Macrophage Activation Syndrome-Hemophagocytic Lymphohistiocytosis.
AnnaCarin HorneTatiana von Bahr GreenwoodSamuel C C ChiangMarie MeethsCaroline BjörklundMaria EkelundPeter ErensjöStefan BergStefan HagelbergYenan T BrycesonUlf AnderssonJan-Inge HenterPublished in: The Journal of rheumatology (2021)
Moderately dosed etoposide may be beneficial in severe and/or refractory MAS-HLH.